541 related articles for article (PubMed ID: 33331994)
1. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
2. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
3. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
[TBL] [Abstract][Full Text] [Related]
4. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
5. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
6. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
[No Abstract] [Full Text] [Related]
7. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors.
Frühwald MC; Hasselblatt M; Nemes K; Bens S; Steinbügl M; Johann PD; Kerl K; Hauser P; Quiroga E; Solano-Paez P; Biassoni V; Gil-da-Costa MJ; Perek-Polnik M; van de Wetering M; Sumerauer D; Pears J; Stabell N; Holm S; Hengartner H; Gerber NU; Grotzer M; Boos J; Ebinger M; Tippelt S; Paulus W; Furtwängler R; Hernáiz-Driever P; Reinhard H; Rutkowski S; Schlegel PG; Schmid I; Kortmann RD; Timmermann B; Warmuth-Metz M; Kordes U; Gerss J; Nysom K; Schneppenheim R; Siebert R; Kool M; Graf N
Neuro Oncol; 2020 Jul; 22(7):1006-1017. PubMed ID: 31883020
[TBL] [Abstract][Full Text] [Related]
8. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
9. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
[TBL] [Abstract][Full Text] [Related]
10. ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
Federico A; Thomas C; Miskiewicz K; Woltering N; Zin F; Nemes K; Bison B; Johann PD; Hawes D; Bens S; Kordes U; Albrecht S; Dohmen H; Hauser P; Keyvani K; van Landeghem FKH; Lund EL; Scheie D; Mawrin C; Monoranu CM; Parm Ulhøi B; Pietsch T; Reinhard H; Riemenschneider MJ; Sehested A; Sumerauer D; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Acta Neuropathol; 2022 Jun; 143(6):697-711. PubMed ID: 35501487
[TBL] [Abstract][Full Text] [Related]
11. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.
Zin F; Cotter JA; Haberler C; Dottermusch M; Neumann J; Schüller U; Schweizer L; Thomas C; Nemes K; Johann PD; Kool M; Frühwald MC; Paulus W; Judkins A; Hasselblatt M
Brain Pathol; 2021 Sep; 31(5):e12967. PubMed ID: 33938067
[TBL] [Abstract][Full Text] [Related]
12. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
[TBL] [Abstract][Full Text] [Related]
13. Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.
Pinto EM; Hamideh D; Bahrami A; Orr BA; Lin T; Pounds S; Zambetti GP; Pappo AS; Gajjar A; Agnihotri S; Broniscer A
Acta Neuropathol; 2018 Aug; 136(2):315-326. PubMed ID: 29428974
[TBL] [Abstract][Full Text] [Related]
14. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
16. SWI/SNF-deficient undifferentiated malignancies: where to draw the line
Tessier-Cloutier B; Kleinman CL; Foulkes WD
J Pathol; 2022 Feb; 256(2):139-142. PubMed ID: 34767264
[TBL] [Abstract][Full Text] [Related]
17. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Johann P; Wu G; Billups CA; Tatevossian RG; Dhanda SK; Srinivasan A; Broniscer A; Qaddoumi I; Vinitsky A; Armstrong GT; Bendel AE; Hassall T; Partap S; Fisher PG; Crawford JR; Chintagumpala M; Bouffet E; Gururangan S; Mostafavi R; Sanders RP; Klimo P; Patay Z; Indelicato DJ; Nichols KE; Boop FA; Merchant TE; Kool M; Ellison DW; Gajjar A
Clin Cancer Res; 2021 May; 27(10):2879-2889. PubMed ID: 33737307
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
19. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
[TBL] [Abstract][Full Text] [Related]
20. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
